Hormonal
In women, visceral adipose tissue (VAT) is significantly more strongly associated with insulin resistance and impaired insulin secretion than abdominal subcutaneous adipose tissue (SAT), whereas in men, both fat depots are associated with insulin resistance to a similar extent.
If you are a woman, carrying fat around your organs (visceral fat) is much more dangerous for your insulin sensitivity than carrying fat under your skin (subcutaneous fat). Men are less discriminating; both types of abdominal fat affect their insulin resistance similarly. Because waist size alone doesn't tell you where the fat is located, relying solely on it may underestimate metabolic risk in women. Focus on reducing overall adiposity, as visceral fat is the primary driver of insulin resistance in women.
In men, abdominal SAT and VAT were associated with insulin resistance to a similar extent, whereas in women particularly visceral fat was associated with insulin resistance and insulin secretion.
Why this rating
Large population-based cross-sectional study (n=2253) with direct MRI assessment of fat depots, though causality is limited by cross-sectional design.
Source
Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study
Renée de Mutsert et al. · Metabolic Syndrome and Related Disorders · 2018
DOI 10.1089/met.2017.0128
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →